AMZN
Amazon.com, Inc.
AMZN has the edge over SABR overall, supported by lower modeled downside and stronger valuation.
SABR
Sabre Corporation
SABR trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SABR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
SABR's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
SABR PE Valuation
SABR has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 20x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over SABR on the outlook, with more favorable profitability expectations.
SABR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect SABR to return to profit, with revenue growing.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SABR on earnings quality, reporting a profit while its opponent remains loss making.
SABR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.09 | — |
| Q3 2026 | -$0.21 | -117% |
| Q2 2026 | $1.83 | +$2.75 |
| Q1 2026 | $1.27 | +$1.72 |
| Q4 2025 | $1.34 | +$2.07 |
| Q3 2025 | $1.22 | +$1.99 |
| Q2 2025 | -$0.92 | +$0.30 |
| Q1 2025 | -$0.45 | +$0.98 |
| Q4 2024 | -$0.73 | +$0.83 |
SABR has swung to a loss: it lost $0.21 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over SABR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
SABR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $738.4M | +3.2% |
| Q2 2026 | $712M | +3.6% |
| Q1 2026 | $760.3M | -2.1% |
| Q4 2025 | $666.5M | -6.7% |
| Q3 2025 | $715.2M | -6.5% |
| Q2 2025 | $687.1M | -10% |
| Q1 2025 | $776.6M | -0.8% |
| Q4 2024 | $714.7M | +4% |
SABR's revenue fell from its 2019 peak and has held roughly level since: $738M last quarter, up 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +1.7 points |
| Q2 2026 | 13% | +0.1 points |
| Q1 2026 | 15% | +1.9 points |
| Q4 2025 | 3.2% | -4.8 points |
| Q3 2025 | 13% | +3.9 points |
| Q2 2025 | 13% | +5 points |
| Q1 2025 | 13% | +0.8 points |
| Q4 2024 | 8% | +2.6 points |
SABR has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SABR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$47.5M | -454% |
| Q2 2026 | $9.7M | +$232.2M |
| Q1 2026 | -$155.4M | -$56.9M |
| Q4 2025 | $115.8M | +74% |
| Q3 2025 | $13.4M | +78% |
| Q2 2025 | -$222.5M | -2877% |
| Q1 2025 | -$98.5M | -$2.7M |
| Q4 2024 | $66.6M | -14% |
SABR has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
SABR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +4.3M shares |
| 1 year | -6% | -25.6M shares |
| 3 years | +17% | +58.5M shares |
| 5 years | +25% | +80.9M shares |
| Available history | +46% | +127M shares |
SABR has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over SABR on leverage, with a lower net debt burden relative to earnings.
SABR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.4x | High |
| Q2 2026 | 8.4x | High |
| Q1 2026 | 8.6x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 7.9x | High |
| Q2 2025 | 10.6x | High |
| Q1 2025 | 10.7x | High |
| Q4 2024 | 10.4x | High |
SABR's net debt is about 8.4 years of its operating earnings (EBITDA), up from 7.9 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SABR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 26.2 | Neutral |
SABR's weekly RSI is 51 (neutral) and its Stochastic is 26 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
SABR PE vs Consumer Cyclical Sector
| Metric | SABR | Sector median | Relative |
|---|---|---|---|
| PE | 0.9x | 18x | 95% below |
| PE % | 5 | 47 | 42 pts below |
SABR has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over SABR on trend strength, trading above more of its moving averages.
SABR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.81 | 5% above |
| 20 week MA | $1.94 | 2.1% below |
| 50 week MA | $1.69 | 12% above |
| 100 week MA | $2.18 | 13% below |
| 200 week MA | $2.98 | 36% below |
SABR's trend is mixed: it's above two of its five weekly moving averages, and 36% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
SABR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.9 | $11.4 | -50% |
| 2021 | $11.4 | $8.91 | -22% |
| 2022 | $8.91 | $5.94 | -33% |
| 2023 | $5.94 | $4.40 | -26% |
| 2024 | $4.40 | $3.67 | -17% |
| 2025 | $3.67 | $1.39 | -62% |
| 2026 YTD | $1.39 | $1.90 | +37% |
SABR has the edge over AMZN on returns for 2026, with the stronger performance.